P576-1902 Screening compound: 2-[5,6-dimethyl-2-(morpholin-4-yl)-4-oxo-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-3-yl]-N-(3-fluorophenyl)acetamide

P576-1902 Screening compound: 2-[5,6-dimethyl-2-(morpholin-4-yl)-4-oxo-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-3-yl]-N-(3-fluorophenyl)acetamide
P576-1902 Screening compound: 2-[5,6-dimethyl-2-(morpholin-4-yl)-4-oxo-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-3-yl]-N-(3-fluorophenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P576-1902
2-[5,6-dimethyl-2-(morpholin-4-yl)-4-oxo-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-3-yl]-N-(3-fluorophenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P576-1902

Molecular Formula

C20H22FN5O3 (C20 H22 FN5 O3)

Compound Name

2-[5,6-dimethyl-2-(morpholin-4-yl)-4-oxo-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-3-yl]-N-(3-fluorophenyl)acetamide

IUPAC name

2-[56-dimethyl-2-(morpholin-4-yl)-4-oxo-3H4H5H-pyrrolo[32-d]pyrimidin-3-yl]-N-(3-fluorophenyl)acetamide

SMILES

Cc1cc(N=C(N(CC(Nc2cccc(F)c2)=O)C2=O)N3CCOCC3)c2n1C

InChI

InChI=1S/C20H22FN5O3/c1-13-10-16-18(24(13)2)19(28)26(20(23-16)25-6-8-29-9-7-25)12-17(27)22-15-5-3-4-14(21)11-15/h3-5,10-11H,6-9,12H2,1-2H3,(H,22,27)

InChI Key

IRSQEAWCWHRKSL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27605316

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

399.42

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.507

Distribution Coefficient, logD

1.506

Water Solubility, LogSw

-2.25

Polar Surface Area

62.525

Acid Dissociation Constant (pKa)

11.10

Base Dissociation Constant (pKb)

-0.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

P576-1902 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with P576-1902 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P576-1902?
Check Price and Availability of P576-1902, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P576-1902 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P576-1902
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P576-1902
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P576-1902 available by request